photo
Speaker

Kiri Granger

DR, MONUMENT THERAPEUTICS
Cheshire, United Kingdom
Kiri is an internationally-recognised expert in the design of clinical trials for CNS disorders, particularly schizophrenia. As Director of Neuroscience at Cambridge Cognition, Kiri provided consultancy to over 50 drug development companies on more than 100 clinical trials and was the lead scientist on a number of successful programs. Kiri chaired the ICSTM working group on schizophrenia clinical trials and is currently an Assistant Professor at the University of Nottingham, Department of Psychology where she is involved in on-going collaborative projects following her PhD research in cognitive and behavioral markers of schizophrenia and anxiety disorders.
Speaking In
4:15 PM - 5:15 PM (PDT)
Wednesday, June 15
Widespread evidence shows that cognitive problems are the second most commonly reported symptom …